Contributions of microdialysis to new alternative therapeutics for hepatic encephalopathy

Liliana Rivera-Espinosa1, Esaú Floriano-Sánchez, José Pedraza-Chaverrí

  • 1Laboratory of Pharmacology, National Institute of Pediatrics, Mexico D.F. 04530, Mexico. lili_rives@yahoo.com

Insights

Hepatic encephalopathy (HE) is a liver complication affecting brain function. Microdialysis aids in understanding HE mechanisms and developing new therapies for better patient care.

Area of Science:

  • Neuroscience
  • Hepatology
  • Biochemistry

Background:

  • Hepatic encephalopathy (HE) is a frequent complication of cirrhosis, characterized by reversible brain dysfunction.
  • The precise mechanisms underlying HE-associated neuronal damage remain largely unknown.
  • Timely diagnosis and novel therapeutic strategies are crucial for managing HE and preventing complications.

Purpose of the Study:

  • To review the contributions of microdialysis in elucidating the physiological alterations in hepatic encephalopathy.
  • To explore the use of microdialysis in experimental models of HE.
  • To discuss studies focused on identifying novel therapeutic alternatives for HE.

Main Methods:

  • The review focuses on the application of microdialysis, a technique for in vivo chemical substance evaluation.
  • Microdialysis involves collecting samples from specific locations using semi-permeable membranes.
  • This method is applied to both human patients with HE and experimental HE models.

Main Results:

  • Microdialysis has provided insights into the physiological changes occurring during hepatic encephalopathy.
  • The technique has been instrumental in studying brain dysfunction in both clinical and preclinical settings.
  • Studies utilizing microdialysis contribute to the search for diagnostic markers and therapeutic targets.

Conclusions:

  • Microdialysis is a valuable tool for understanding the complex pathophysiology of hepatic encephalopathy.
  • Continued research using microdialysis is essential for advancing diagnostic capabilities and therapeutic interventions for HE.
  • This approach holds promise for improving patient outcomes in hepatic encephalopathy.

Related Concept Videos

Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...